Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the international BFM study group

1. Biondi, A.
2. Valsecchi, M.G.
3. Seriu, T.
4. D'Aniello, E.
5. Willemse, M.J.
6. Fasching, K.
7. Pannunzio, A.
8. Gadner, H.
9. Schrappe, M.
10. Kamps, W.A.
11. Bartram, C.R.
12. Van Dongen, J.J.M.
13. Panzer-Grümayer, E.R.